SCM
NVAX icon

Shah Capital Management’s Novavax NVAX Stock Holding History

Shah Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$121M Buy
14,845,097
+286,317
+2% +$2.6M 23.18% 2
2025
Q4 		$97.8M Buy
14,558,780
+2,747,000
+23% +$20.7M 18.87% 2
2025
Q3 		$102M Buy
11,811,780
+300,000
+3% +$2.33M 18.32% 2
2025
Q2 		$72.5M Buy
11,511,780
+379,934
+3% +$2.52M 14.11% 3
2025
Q1 		$71.4M Sell
11,131,846
-17,000
-0.2% -$141K 14.58% 2
2024
Q4 		$89.6M Buy
11,148,846
+1,333,305
+14% +$12.9M 18.08% 2
2024
Q3 		$124M Buy
9,815,541
+153,451
+2% +$1.98M 24.16% 2
2024
Q2 		$122M Buy
9,662,090
+1,544,263
+19% +$15.5M 26.46% 2
2024
Q1 		$38.8M Buy
8,117,827
+337,071
+4% +$1.56M 10.86% 3
2023
Q4 		$37.3M Buy
7,780,756
+1,450,000
+23% +$8.88M 9.57% 4
2023
Q3 		$45.8M Buy
6,330,756
+850,000
+16% +$6.79M 10.84% 4
2023
Q2 		$40.7M Buy
5,480,756
+1,229,680
+29% +$9.67M 10.35% 5
2023
Q1 		$29.5M Buy
4,251,076
+3,536,076
+495% +$32.5M 8.57% 5
2022
Q4 		$7.35M Buy
+715,000
New +$12.6M 1.75% 11

Other funds holding NVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Shah Capital Management's NVAX Position: Q1 2026 in Review

Shah Capital Management increased its Novavax (NVAX) stake by 2% in Q1 2026, buying an estimated $2.6M and bringing the position to 14,845,097 shares worth $121M. The position accounts for 23.18% of the portfolio, ranked #2.

Shah Capital Management first reported a position in NVAX in Q4 2022 and has held it in 14 quarters since. The position peaked at $124M in Q3 2024. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Shah Capital Management held 14,845,097 shares of Novavax worth $121M as of Q1 2026.
  • Shah Capital Management bought 286,317 Novavax shares in Q1 2026, an estimated $2.6M.
  • Novavax made up 23.18% of Shah Capital Management's portfolio in Q1 2026, its #2 holding.
  • Shah Capital Management first reported a position in Novavax in Q4 2022 and has held it in 14 quarters since.
  • Shah Capital Management's Novavax position peaked at $124M in Q3 2024.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Shah Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.